Eli Lilly began clinical testing of therapies for COVID-19
On Apr. 10, 2020, Eli Lilly announced it had entered into an agreement with the National Institute of…
NIH began clinical trial of hydroxychloroquine as potential therapy for COVID-19
On Apr. 9, 2020, the first participants were enrolled in the trial at Vanderbilt University Medical Center, Nashville,…
Laurent Pharmaceuticals joined battle against COVID-19
On Apr. 9, 2020, Laurent Pharmaceuticals announced that a spin off from McGill University planned to test its…
Stanford-led team developed privacy-focused coronavirus alert app
On Apr. 9, 2020, James Petrie, a graduate student in applied mathematics at the University of Waterloo in…
Washington University launched Clinical trial to evaluate COVID-19 treatment
On Apr. 9, 2020, Washington University School of Medicine in St. Louis launched a clinical trial for patients…
BioCryst began clinical trial with Galidesivir for treatment of patients with COVID-19
On Apr. 9, 2020, BioCryst Pharmaceuticals announced the company has opened enrollment into a randomized, double-blind, placebo-controlled clinical…
Chembio Diagnostics and Stony Brook Medicine collaborated to identify Coronavirus survivors
On Apr. 9, 2020, Chembio Diagnostics has been selected for use in a Stony Brook Medicine effort to…
Carl Wesolowski discovered that metformin stays in the body for a lengthy period of time if delivered intravenously.
On Apr. 9, 2020, Dr. Carl Wesolowski at the University of Saskatchewan discovered that metformin, often used to…
Autoimmunity may be rising in the United States
On Apr. 8, 2020, NIH scientists and collaborators report that autoimmunity, a condition in which the bodyﾒs immune…
Philips and US government collaborate in ventilator production ramp up to combat COVID-19 pandemic
On Apr. 8, 2020, Philips announced that the U.S. Government and Philips agreed to team up to increase…
Abbott FreeStyleﾮ Libre 14 Day System available in US for hospitalized patients with diabetes during COVID-19 pandemic
On Apr. 8, 2020, Abbott announced that the FreeStyle Libre 14 day system, a continuous glucose monitoring (CGM)…
![Dynavax donated 10,000 doses of HEPLISAV-Bﾮ [Hepatitis B Vaccine (Recombinant), adjuvanted] vaccine to emergency healthcare providers](https://www.lifesciencehistory.com/wp-content/uploads/2024/05/dynavax_logo-3.png){kind=logo}
Dynavax donated 10,000 doses of HEPLISAV-Bﾮ [Hepatitis B Vaccine (Recombinant), adjuvanted] vaccine to emergency healthcare providers
On Apr. 8, 2020, Dynavax Technologies announced it had donated 10,000 doses of HEPLISAV-B adult vaccine to help…
PharmaCyte Biotech entered into license agreement for COVID-19 diagnostic kits
On Apr. 8, 2020, PharmaCyte Biotech announced a license agreement with Hai Kang Life Corp. whereby PharmaCyte received…
Nanomix awarded BARDA contract for development of rapid, mobile, point-of-care assays to detect COVID-19
On Apr. 8, 2020, Nanomix announced that the company had been awarded $570,000 in funding from Biomedical Advanced…
Vanda Pharma and University of Illinois at Chicago announce partnership to identify novel antivirals against COVID-19
On Apr. 8, 2020, Vanda Pharmaceuticals and the University of Illinois at Chicago (UIC) announced a research partnership…
Novavax identified Coronavirus vaccine candidate; accelerated initiation of first-in-human trial to mid-May
On Apr. 8, 2020, Novavax announced it had identified a coronavirus vaccine candidate, NVX-CoV2373, a stable, prefusion protein…
Pacific Biosciences powers SARS-CoV-2 research at commercial, academic and government labs
On Apr. 8, 2020, Pacific Biosciences announced it is working with commercial, academic and government research teams that…
Bellerophon Therapeutics submitted investigational NDA to study INOpulseﾮ inhaled nitric oxide for treatment of COVID-19
On Apr. 8, 2020, Bellerophon Therapeutics announced submission of an Investigational New Drug (IND) application to the FDA…
FDA approved BRAFTOVIﾮ (Encorafenib) in combination with Cetuximab for treatment of BRAFV600E-mutant metastatic colorectal cancer
On Apr. 9, 2020, Pfizer announced that the FDA had approved BRAFTOVIﾮ (encorafenib) in combination with cetuximab (marketed…
Chembio received second UNICEF order for $15 Million
On Apr. 8, 2020, Chembio Diagnostics announced a second $1.5 million purchase order from UNICEF for multiplex Zika,…
CSL Behring and SAB Biotherapeutics joined forces to deliver new potential COVID-19 therapeutic
On Apr. 8, 2020, CSL Behring and SAB Biotherapeutics announced a partnership to combat the coronavirus pandemic with…
Texas A&M Researchers designed 3D-printed diffuser to treat COVID-19 patients
On Apr. 8, 2020, a team of Texas A&M University researchers led by Michael R. Moreno, in collaboration…
Repurposing existing drugs could offer faster path to COVID-19 treatment
On Apr. 7, 2020, a map of interactions between the novel coronavirus and human proteins is helping scientists…
Pluristem reported preliminary data from COVID-19 Compassionate Use Program, treating seven patients with acute respiratory failure
On Apr. 7, 2020, Pluristem Therapeutics announced preliminary data from its compassionate use program, treating seven patients suffering…
Queensland University leads international team researching ancient Australian plant to help in production of COVID-19 vaccine
On Apr. 7, 2020, the Queensland University of Technology (QUT) announced that it is leading an international team…
FDA approved Emory University human clinical trials for Emory COVID-19 antiviral
On Apr. 7, 2020, the FDA approved an Investigational New Drug application by Drug Innovation Ventures at Emory…
Successful MERS vaccine in mice may hold promise for COVID-19 vaccine
On Apr. 7, 2020, Researchers at the University of Iowa and the University of Georgia announced they had…
Harvard, MIT and Stanford commited to COVID-19 technology licensing principles, maximizing access to innovations
On Apr. 7, 2020, Harvard University, Massachusetts Institute of Technology, and Stanford University announced they had established and…
Seattle area philanthropists responded to COVID-19 care and research needs
On Apr. 7, 2020, the University of Washington Medicine annouced that more than $20 million has been raised…
Alzheimerﾒs trial screening data links high amyloid levels with early stage disease
On Apr. 6, 2020, the first published data from the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4) study…